PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 25.2 EUR 1.61% Market Closed
Market Cap: 302.2m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

PharmaSGP Holding SE
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Operating Income Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Operating Income
€24.6m
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Operating Income
-$125.5m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Operating Income
€2.2B
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Merck KGaA
XETRA:MRK
Operating Income
€3.4B
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Operating Income
-€1.1m
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Operating Income
€191.1m
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Operating Income?
Operating Income
24.6m EUR

Based on the financial report for Dec 31, 2023, PharmaSGP Holding SE's Operating Income amounts to 24.6m EUR.

What is PharmaSGP Holding SE's Operating Income growth rate?
Operating Income CAGR 5Y
5%

Over the last year, the Operating Income growth was 39%. The average annual Operating Income growth rates for PharmaSGP Holding SE have been 19% over the past three years , 5% over the past five years .

Back to Top